IL129351A0 - Hiv and cancer treatment - Google Patents

Hiv and cancer treatment

Info

Publication number: IL129351A0
Authority: IL; Israel
Prior art keywords: hiv; cancer treatment; cancer; treatment
Prior art date: 1997-05-16

Application number

IL12935197A

Original Assignee

Procter & Gamble

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-16

Filing date

1997-11-26

Publication date

2000-02-17

1997-11-26 Application filed by Procter & Gamble filed Critical Procter & Gamble

2000-02-17 Publication of IL129351A0 publication Critical patent/IL129351A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

IL12935197A 1997-05-16 1997-11-26 Hiv and cancer treatment IL129351A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4672697P	1997-05-16	1997-05-16
PCT/US1997/021564 WO1998051303A1 (en)	1997-05-16	1997-11-26	Hiv and cancer treatment

Publications (1)

Publication Number	Publication Date
IL129351A0 true IL129351A0 (en)	2000-02-17

Family

ID=21945046

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12935197A IL129351A0 (en)	1997-05-16	1997-11-26	Hiv and cancer treatment

Country Status (19)

Country	Link
EP (1)	EP0954309A1 (en)
JP (1)	JP2000510156A (en)
KR (1)	KR20000049064A (en)
CN (1)	CN1254281A (en)
AR (1)	AR009968A1 (en)
AU (1)	AU7402998A (en)
BR (1)	BR9712981A (en)
CA (1)	CA2268848A1 (en)
CO (1)	CO5070657A1 (en)
CZ (1)	CZ124999A3 (en)
HU (1)	HUP9904092A3 (en)
IL (1)	IL129351A0 (en)
NO (1)	NO991701L (en)
PE (1)	PE11499A1 (en)
PL (1)	PL335160A1 (en)
SK (1)	SK46999A3 (en)
TR (1)	TR199901530T2 (en)
WO (1)	WO1998051303A1 (en)
ZA (1)	ZA979095B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6479526B1 (en)	1995-04-12	2002-11-12	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en)	1995-04-12	2001-07-17	The Proctor & Gamble Company	Methods of treating cancer with benzimidazoles
US6177460B1 (en)	1995-04-12	2001-01-23	The Procter & Gamble Company	Method of treatment for cancer or viral infections
US5770616A (en)	1995-06-07	1998-06-23	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en)	1995-06-07	2001-07-24	The Proctor & Gamble Company	Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en)	1995-08-04	2004-02-03	University Of Arizona Foundation	N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en)	1997-01-28	1999-05-04	The Procter & Gamble Company	Method for inhibiting the growth of cancers
US6506783B1 (en)	1997-05-16	2003-01-14	The Procter & Gamble Company	Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en)	1998-05-19	2001-06-12	The Procter & Gamble Company	HIV and viral treatment
WO2000050021A2 (en) *	1999-02-26	2000-08-31	Napro Biotherapeutics, Inc.	Treatment regimen for prostate cancer, initiated after androgen ablative therapy has started
CA2366697A1 (en) *	1999-02-26	2000-08-31	Larry Helson	Treatment regimen for hormone-sensitive cancers
US6423734B1 (en)	1999-08-13	2002-07-23	The Procter & Gamble Company	Method of preventing cancer
AU2001286744A1 (en) *	2000-08-25	2002-03-04	Beth Israel Deaconess Medical Center	Compounds and methods for inhibiting neuronal cell death
US6380232B1 (en)	2000-09-26	2002-04-30	The Procter & Gamble Company	Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
AU9279601A (en) *	2000-09-26	2002-04-08	Procter & Gamble	Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) *	2000-09-26	2002-06-18	The Procter & Gamble Company	Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en)	2000-09-26	2002-10-08	The Procter & Gamble Company	Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en)	2000-09-26	2003-08-19	University Of Arizona Foundation	Compounds and methods for use thereof in the treatment of cancer or viral infections
WO2002041891A2 (en) *	2000-11-01	2002-05-30	The Procter & Gamble Company	Hiv treatment with benzimidazoles
JP2004115397A (en) *	2002-09-25	2004-04-15	Fuji Photo Film Co Ltd	Liposome comprising therapeutic agent for vascular disease
AU2005313839B2 (en) *	2004-12-06	2010-03-11	Pitney Pharmaceuticals Pty Limited	Treatment for cancer
EP1830847B1 (en)	2004-12-06	2014-11-19	Pitney Pharmaceuticals Pty Limited	Treatment for cancer
US7727967B2 (en) *	2006-02-24	2010-06-01	Boise State University	Cyanooxime inhibitors of carbonyl reductase and methods of using said inhibitors in treatments involving anthracyclines
WO2009043093A1 (en) *	2007-10-04	2009-04-09	Newsouth Innovations Pty Limited	Hif inhibition
CN101643729B (en) *	2008-08-07	2011-12-28	复旦大学	Nucleic acid molecule NRN1SR22 and application thereof in preparation of anticancer medicaments
EP3119768B1 (en)	2014-03-16	2019-07-31	Hadasit Medical Research Services And Development Ltd.	3,4-bromo or -sulfonate substituted 1h-pyrrole-2,5-dione derivatives as type iii deiodinase (dio3) inhibitors for treating depressions and cancer
CN105418711A (en) *	2015-11-06	2016-03-23	山东大学	Application of alpha-L-rhamnosidase to preparing hydroxycarbamide and glycoside derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1090186C (en) *	1993-03-31	2002-09-04	麦克公司	HIV protease inhibitors in pharmaceutical combinations for the treatment of AIDS
US5656615A (en) *	1995-04-12	1997-08-12	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals
US5665713A (en) *	1995-04-12	1997-09-09	Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of viruses and cancers
WO1996032104A1 (en) *	1995-04-12	1996-10-17	The Procter & Gamble Company	A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
HUP9903420A3 (en) *	1995-08-04	2001-12-28	Procter & Gamble	Use of fluconazole for the preparation of pharmaceutical compositions, inhibiting the growth of cancers and treating viral infections

1997
- 1997-10-09 PE PE1997000894A patent/PE11499A1/en not_active Application Discontinuation
- 1997-10-10 AR ARP970104697A patent/AR009968A1/en unknown
- 1997-10-10 ZA ZA9709095A patent/ZA979095B/en unknown
- 1997-11-07 CO CO97065469A patent/CO5070657A1/en unknown
- 1997-11-26 KR KR1019990703137A patent/KR20000049064A/en not_active Application Discontinuation
- 1997-11-26 IL IL12935197A patent/IL129351A0/en unknown
- 1997-11-26 CA CA002268848A patent/CA2268848A1/en not_active Abandoned
- 1997-11-26 CN CN97182189A patent/CN1254281A/en active Pending
- 1997-11-26 PL PL97335160A patent/PL335160A1/en unknown
- 1997-11-26 AU AU74029/98A patent/AU7402998A/en not_active Abandoned
- 1997-11-26 TR TR1999/01530T patent/TR199901530T2/en unknown
- 1997-11-26 BR BR9712981-0A patent/BR9712981A/en unknown
- 1997-11-26 HU HU9904092A patent/HUP9904092A3/en unknown
- 1997-11-26 CZ CZ991249A patent/CZ124999A3/en unknown
- 1997-11-26 WO PCT/US1997/021564 patent/WO1998051303A1/en not_active Application Discontinuation
- 1997-11-26 SK SK469-99A patent/SK46999A3/en unknown
- 1997-11-26 EP EP97949599A patent/EP0954309A1/en not_active Withdrawn
- 1997-11-26 JP JP10522997A patent/JP2000510156A/en active Pending
1999
- 1999-04-09 NO NO991701A patent/NO991701L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
CO5070657A1 (en)	2001-08-28
NO991701D0 (en)	1999-04-09
SK46999A3 (en)	2000-05-16
BR9712981A (en)	2000-04-18
HUP9904092A2 (en)	2000-04-28
WO1998051303A1 (en)	1998-11-19
CA2268848A1 (en)	1998-11-19
EP0954309A1 (en)	1999-11-10
PE11499A1 (en)	1999-03-01
ZA979095B (en)	1998-05-11
JP2000510156A (en)	2000-08-08
NO991701L (en)	2000-01-17
HUP9904092A3 (en)	2000-07-28
TR199901530T2 (en)	1999-10-21
PL335160A1 (en)	2000-04-10
CZ124999A3 (en)	1999-09-15
AU7402998A (en)	1998-12-08
CN1254281A (en)	2000-05-24
KR20000049064A (en)	2000-07-25
AR009968A1 (en)	2000-05-17

Publication	Publication Date	Title
ZA979096B (en)	1998-08-28	Viral and cancer treatment
IL129351A0 (en)	2000-02-17	Hiv and cancer treatment
EG24678A (en)	2010-04-27	Combination therapy
AU7718898A (en)	1998-12-21	Txu-7-pap immunotoxin and use thereof
HU9602965D0 (en)	1997-01-28	Cancer treatment and metastasis prevention
IL127306A0 (en)	1999-09-22	Combination therapy
GB9700899D0 (en)	1997-03-05	Novel treatment
GB9700939D0 (en)	1997-03-05	Therapy
GB9303210D0 (en)	1993-03-31	Cancer treatment
ZA985253B (en)	1999-06-17	Quinolines and their therapeutic use
GB9703633D0 (en)	1997-04-09	Cancer therapy
EP0998578A4 (en)	2003-04-09	Sel-10 AND USES THEREOF
AU5871898A (en)	1998-08-25	Microparticles and their use in cancer treatment
GB9712869D0 (en)	1997-08-20	Hair treatment
GB9804361D0 (en)	1998-04-22	Cancer treatment
GB9701117D0 (en)	1997-03-12	HIV Treatment
GB9708380D0 (en)	1997-08-13	HIV treatment
GB9721978D0 (en)	1997-12-17	Treatment of depression
GB9721692D0 (en)	1997-12-10	Novel treatment
AU6409598A (en)	1998-09-29	An improvement in the treatment of wastes
GB9716742D0 (en)	1997-10-15	Treatment
GB9707104D0 (en)	1997-05-28	An improvement in the treatment of bio-waste
GB9424578D0 (en)	1995-03-01	Cancer treatment
GB9716289D0 (en)	1997-10-08	Tumour treatment
GB9605476D0 (en)	1996-05-15	HIV gene therapy